BioInvent International AB banner
B

BioInvent International AB
STO:BINV

Watchlist Manager
BioInvent International AB
STO:BINV
Watchlist
Price: 25.2 SEK -3.26% Market Closed
Market Cap: kr1.7B

Wall Street
Price Targets

BINV Price Targets Summary
BioInvent International AB

Wall Street analysts forecast BINV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BINV is 78.2 SEK with a low forecast of 60.6 SEK and a high forecast of 94.5 SEK.

Lowest
Price Target
60.6 SEK
140% Upside
Average
Price Target
78.2 SEK
210% Upside
Highest
Price Target
94.5 SEK
275% Upside
BioInvent International AB Competitors:
Price Targets
SDGR
Schrodinger Inc
116% Upside
FBIZ
First Business Financial Services Inc
18% Upside

Revenue
Forecast

-8% / Year
Past Growth
134% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss
-8% / Year
Past Growth
134% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss

For the last 13 years the compound annual growth rate for BioInvent International AB's revenue is -8%. The projected CAGR for the next 3 years is 134%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-78%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-78%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BINV's stock price target?
Price Target
78.2 SEK

According to Wall Street analysts, the average 1-year price target for BINV is 78.2 SEK with a low forecast of 60.6 SEK and a high forecast of 94.5 SEK.

What is BioInvent International AB's Revenue forecast?
Projected CAGR
134%

For the last 13 years the compound annual growth rate for BioInvent International AB's revenue is -8%. The projected CAGR for the next 3 years is 134%.

Back to Top